U.S. Minor Cannabinoids Market Size & Forecast to 2030

The U.S. minor cannabinoids market is expected to reach USD 33.3 billion by 2030. The market is expected to expand at a CAGR of 15% from 2024 to 2030. Rising use of cannabinoid-based products and awareness regarding the health benefits associated with cannabinoid consumption are some of the crucial factors supporting the growth.

Minor cannabinoids have potential therapeutic benefits, including anti-inflammatory, analgesic, and neuroprotective effects. There is a growing interest in developing pharmaceuticals and nutraceuticals containing minor cannabinoids for the treatment of various medical conditions, such as chronic pain, anxiety, and sleep disorders. For instance, in January 2021, Lygos, Inc. announced the commercial availability of cannabichromene (CBC) that has a wide range of anti-inflammatory, antioxidant, and pain management properties.

Wellness products such as supplements, tinctures, and topicals incorporate minor cannabinoids. These products are marketed as natural remedies for various health issues, and are becoming popular among consumers who are looking for alternatives to traditional medications. For instance, Nextraction, a supplier of personal care and health & wellness products, launched Kriva - a range of Cannabinol (CBN), cannabidiol acid (CBDA), and Cannabigerolic acid (CBGA) - in topical and ingestible formulas.

Various organic and inorganic developments done by key players to strengthen their business avenues and footprints in the U.S. minor cannabinoids industry are anticipated to facilitate market expansion over the forecast period. In October 2022, Purissima, Inc., a biotechnology company in partnership with Open Book Extracts (OBX), launched its first fermentation-derived natural CBC products such as gummies, topical serums, tinctures, and capsules.

U.S. Minor Cannabinoids Market Report Highlights

Based on product type, the tetrahydrocannabivarin (THCV) segment dominated the market with a revenue share of 25.9% in 2023, owing to increasing application of THCV in the management of conditions such as arthritis, metabolic disorders, and epilepsy
Based on application, the neurological disorders segment accounted for a significant revenue share in 2023, due to the rising prevalence of neurological disorders and applications of cannabinoids in their management
Some of the major market players include GCM Holdings (Global Cannabinoids), LLC, GenCanna, Mile High Labs, ZERO POINT EXTRACTION, LLC, BulKanna, and CBD. INC.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product Type
1.2.2. Application
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product type outlook
2.2.2. Application outlook
2.3. Competitive Insights

Chapter 3. U.S. Minor Cannabinoids Market Variables, Trends & Scope

3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. U.S. Minor Cannabinoids Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. U.S. Minor Cannabinoids Market: Product Type Estimates & Trend Analysis

4.1. Product Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Minor Cannabinoids Market by Product Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Cannabigerol (CBG)
4.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Cannabichromene (CBC)
4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Cannabinol (CBN)
4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. Tetrahydrocannabivarin (THCV)
4.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.5. Cannabigerolic acid (CBGA)
4.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.6. Others
4.4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. U.S. Minor Cannabinoids Market: Application Estimates & Trend Analysis

5.1. Application Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global U.S. Minor Cannabinoids Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Inflammation
5.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2. Pain Management
5.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.3. Neurological Disorders
5.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.4. Cancer
5.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.5. Others
5.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

6.1. Recent Developments & Impact Analysis, by Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. Mile High Labs
6.3.1.1. Company overview
6.3.1.2. Financial performance
6.3.1.3. Product benchmarking
6.3.1.4. Strategic initiatives
6.3.2. GCM Holdings, LLC
6.3.2.1. Company overview
6.3.2.2. Financial performance
6.3.2.3. Product benchmarking
6.3.2.4. Strategic initiatives
6.3.3. GenCanna.
6.3.3.1. Company overview
6.3.3.2. Financial performance
6.3.3.3. Product benchmarking
6.3.3.4. Strategic initiatives
6.3.4. CBD. INC.
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Rhizo Sciences
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Laurelcrest
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Fresh Bros Hemp Company
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. BulKanna
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. High Purity Natural Products
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. ZERO POINT EXTRACTION, LLC
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. minor cannabinoids market, by product type, 2018-2030 (USD Million)
Table 3 U.S. minor cannabinoids market, by application, 2018-2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. minor cannabinoids market: market outlook
Fig. 9 U.S. minor cannabinoids competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 U.S. minor cannabinoids market driver impact
Fig. 15 U.S. minor cannabinoids market restraint impact
Fig. 16 U.S. minor cannabinoids market strategic initiatives analysis
Fig. 17 U.S. minor cannabinoids market: Product type movement analysis
Fig. 18 U.S. minor cannabinoids market: Product type outlook and key takeaways
Fig. 19 Cannabigerol (CBG)market estimates and forecast, 2018-2030
Fig. 20 Cannabichromene (CBC) market estimates and forecast, 2018-2030
Fig. 21 Cannabinol (CBN) market estimates market and forecast, 2018-2030
Fig. 22 Tetrahydrocannabivarin (THCV) market estimates and forecast, 2018-2030
Fig. 23 Cannabigerolic acid (CBGA) market estimates and forecast, 2018-2030
Fig. 24 Others (Cannabidiolic Acid (CBDA), Cannabidivarin (CBDV), And Other Minor Cannabinoids) estimates and forecast, 2018-2030
Fig. 25 U.S. minor cannabinoids market: Application movement Analysis
Fig. 26 U.S. minor cannabinoids market: Application outlook and key takeaways
Fig. 27 Inflammation market estimates and forecasts, 2018-2030
Fig. 28 Pain management market estimates and forecasts, 2018-2030
Fig. 29 Neurological disorders market estimates and forecasts,2 018 - 2030
Fig. 30 Cancer market estimates and forecasts, 2018-2030
Fig. 31 Others market estimates and forecasts, 2018-2030

Companies Mentioned

Mile High Labs
GCM Holdings, LLC
GenCanna.
CBD. INC.
Rhizo Sciences
Laurelcrest
Fresh Bros Hemp Company
BulKanna
High Purity Natural Products
ZERO POINT EXTRACTION, LLC

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	80
Published	January 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 11.5 Billion
Forecasted Market Value ( USD ) by 2030	$ 33.3 Billion
Compound Annual Growth Rate	15.0%
Regions Covered	United States
No. of Companies Mentioned	10

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3473EUR$3,500USD£2,883GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€4465EUR$4,500USD£3,706GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€6450EUR$6,500USD£5,354GBP

U.S. Minor Cannabinoids Market Size, Share & Trends Analysis Report by Product (Cannabigerol (CBG), Tetrahydrocannabivarin (THCV), Cannabichromene (CBC)), Application (Cancer, Inflammation, Neurological Disorders), and Segment Forecasts, 2024-2030

U.S. Minor Cannabinoids Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

U.S. Minor Cannabinoids Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Minor Cannabinoids Market by Products, Application - Global Forecast 2025-2030

Cannabis Pharmaceuticals Market Size, Share & Trends Analysis Report by Brand Type (Sativex, Epidiolex, Other Brands), Region (North America, Middle East and Africa, Asia-Pacific, Europe), and Segment Forecasts, 2024-2030

North America Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By Derivatives (CBD, THC), By Cultivation, By End Use (Medical, Recreational, Industrial), By Region, And Segment Forecasts, 2024 - 2030

Europe Medical Cannabis Oil Market, By Derivatives, By Source , By Application , By Route of Administration , By End User , By Distribution Channel By Country - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2024-2032.

Cannabinoid Hemp Oil Market by Form, Source, Distribution Mode, Application - Global Forecast 2025-2030

About the Minor Cannabinoids Market